Dr. Moon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
393 E Walnut St
Fl 3
Pasadena, CA 91188Phone+1 951-353-4931
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2008 - 2009- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2007 - 2008
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2006 - 2007
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2003 - 2006
Keck School of Medicine of the University of Southern CaliforniaClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Start of enrollment: 2023 Sep 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 50 citationsEnfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig
Journal of Clinical Oncology. 2023-09-01 - 157 citationsCombination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen
Journal of Clinical Oncology. 2023-01-10 - 34 citationsOverall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM re...Mayer Fishman, Janice P. Dutcher, Joseph I. Clark, Ajjai Alva, Gerald P Miletello
Journal for Immunotherapy of Cancer. 2019-03-27
Press Mentions
14 of the Best Books for New DadsApril 12th, 2021- ECOG-ACRIN Cancer Research Group Melanoma Research Team Led by Michael Atkins, MD, Receives the 2023 Paper of the Year Distinction from the Journal of Clinical OncologyJanuary 19th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
